CopyMark Law Group
4.9/5
Drawing for EQUIL

USPTO serial 79276031

EQUIL

Reviewed by CopyMark Law Group

Reg. 6450816Status 700Renewal
Filing date
Status date
Registration date
Aug 17, 2021
Examiner
REID, CAILE MAUREEN
Law office
PUBLICATION AND ISSUE SECTION

What this means

This registration is in, or will soon enter, a USPTO maintenance window. Missing a Section 8 or Section 9 filing can cancel the registration.

Status 700: Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six.

Need help with EQUIL?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Get help with this Renewal, set up monitoring, or talk with CopyMark.
Get Attorney Assistance for just $399*

Plus Government fees of $325

Trademark Monitoring(312) 319-4460
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Start a new application
(312) 319-4460

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Nazly Aileen Bayramoglu

Nazly Aileen Bayramoglu Bayramoglu Law Offices LLCSuite 1001540 West Warm Springs RoadHenderson, NV 89014

Goods and services

ClassDescriptionStatusFirst use
010Catheters; vacuum pumps for medical purposes; blood testing apparatus; hypodermic syringes; medical apparatus and instruments for use in monitoring and controlling blood sugar levels, namely, a patch insulin pump system; trocars; syringes for medical purposes; Apparatus for use in medical analysis, namely, insulin infusion pumps, also comprising diagnostic instruments for the analysis of blood glucose levels, sold as a unit; testing apparatus for medical purposes, namely, apparatus for monitoring and controlling blood glucose levels, in particular with the use of bolus and basal insulin infusions, blood glucose testing, and bolus infusion size calculations; diagnostic apparatus for medical purposes, namely, insulin delivery diagnostic apparatus for detecting low blood glucose levels, and insulin infusion diagnostic apparatus for monitoring blood glucose levelsACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Aug 17, 2026REM3COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED—
Mar 21, 2022FINOFINAL DECISION TRANSACTION PROCESSED BY IB—
Jan 25, 2022XXSSGENERIC MADRID TRANSACTION SENT TO IB—
Jan 25, 2022XXCRGENERIC MADRID TRANSACTION CREATED—
Nov 17, 2021FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB—
Aug 21, 2021ADCHCHANGE OF NAME/ADDRESS REC'D FROM IB—
Aug 17, 2021R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Jul 4, 2021OPNXNOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB—
Jun 9, 2021OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB—
Jun 9, 2021OPNRNOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB—
Jun 7, 2021GPNXNOTIFICATION PROCESSED BY IB—
Jun 1, 2021NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Jun 1, 2021PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
May 12, 2021OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB—
May 12, 2021OP2RNOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB—
May 12, 2021NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Apr 27, 2021CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Apr 27, 2021XAECEXAMINER'S AMENDMENT ENTERED—
Apr 27, 2021GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Apr 27, 2021GNEAEXAMINERS AMENDMENT E-MAILED—
Apr 27, 2021CNEAEXAMINERS AMENDMENT -WRITTEN—
Apr 22, 2021TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Apr 22, 2021CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Apr 19, 2021ALIEASSIGNED TO LIE—
Apr 7, 2021ALIEASSIGNED TO LIE—
Jan 7, 2021ERSITEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED—
Jun 10, 2020GNS3NOTIFICATION OF LETTER OF SUSPENSION E-MAILED—
Jun 10, 2020GNSLLETTER OF SUSPENSION E-MAILED—
Jun 10, 2020CNSLSUSPENSION LETTER WRITTEN—
May 21, 2020CHANAPPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED—
May 21, 2020TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
May 21, 2020ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
May 21, 2020REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
May 21, 2020COARTEAS CHANGE OF OWNER ADDRESS RECEIVED—
Apr 17, 2020RFNTREFUSAL PROCESSED BY IB—
Apr 2, 2020RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
Apr 2, 2020RFRRREFUSAL PROCESSED BY MPU—
Mar 19, 2020RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Mar 18, 2020CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Mar 10, 2020DOCKASSIGNED TO EXAMINER—
Jan 14, 2020MAFRAPPLICATION FILING RECEIPT MAILED—
Jan 10, 2020NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Jan 9, 2020REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance